Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-01-01 @ 10:25 PM
Study NCT ID:
NCT04659369
Status:
TERMINATED
Last Update Posted:
2024-04-09
First Post:
2020-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
Sponsor:
Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CMAB819-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None